Myo-Inositol for Fertility: Benefits & Dosage

Quick Answer: Myo-Inositol for Fertility

Myo-inositol has been studied in PCOS and assisted reproduction, but a universal fertility benefit, dose or best formulation is not established. Current international guidance treats infertility use as experimental. Some studies report metabolic or reproductive improvements; others do not, and the outcome matters. Current guideline source.

This guide distinguishes study amounts from manufacturer serving sizes and a personal treatment recommendation. It also separates myo-inositol alone, myo/D-chiro mixtures, treatment alongside prescribed medicines and use during pregnancy.

What the Evidence Actually Studied

Inositol research: populations, amounts and limits
SourcePopulation / designWhat was tested or measuredImportant limit
Fitz et al., 202430 PCOS trials in a guideline-informing reviewDifferent inositol preparations and outcomesLimited, inconclusive overall evidence; no universally recommended form or dose
Akbari Sene et al., 201950 patients with PCOS undergoing ART4 g/day myo-inositol plus folic acid; oocyte, fertilization and embryo measuresSmall study; these outcomes do not establish a live-birth benefit or a brand winner
2026 umbrella review13 meta-analyses of randomized trialsFavorable signals including some reproductive measuresMost evidence items were low or very low quality; overlapping reviews are not 13 independent new trials
2026 ART-focused reviewStudies involving metformin or myo-inositol in PMOS/PCOSMyo-inositol improved menstrual regularity in pooled resultsNo significant clinical-pregnancy effect for myo-inositol in that review
2026 comparative trial240 participants across four letrozole-based groupsMyo-inositol, chromium or L-arginine added to treatmentReported favorable short-term outcomes; adjunct use does not establish effectiveness alone or a live-birth result

The older Unfer review reported improvements in metabolic measures. Those findings should not be relabeled as a universal clinical-pregnancy or live-birth result. Unfer et al., 2017. The newer syntheses differ in eligibility, comparisons and evidence appraisal; a positive pooled estimate needs that context.

Myo-Inositol Dosage: What Does 4 g in a Trial Mean?

The small ART trial above used 4 g of myo-inositol daily with folic acid. That is a description of its intervention in a specific patient group, not a dose recommendation for every person with PCOS, unexplained infertility or an IVF appointment. Its study period also cannot promise a time to restored ovulation. Trial record.

The international guideline does not recommend a specific inositol type, dose or combination because the supporting evidence is insufficient. A label direction, a study amount and an individual decision therefore answer different questions. Guideline recommendations.

Myo-Inositol, D-Chiro-Inositol and the 40:1 Ratio

A 40:1 label describes relative quantities. For example, 2,000 mg of myo-inositol and 50 mg of D-chiro-inositol make a 40:1 mixture. The arithmetic does not prove that the ratio is optimal for a particular patient or that every tissue maintains one universal ratio.

A frequently cited review describes a biological rationale and promising early findings for combined use, while calling for confirmation. It is not a head-to-head fertility-outcome trial proving a best retail ratio. Monastra et al., 2017. Current guidance and newer evidence should be considered alongside such mechanistic arguments.

Comparing the Previously Discussed Products by Label

The following comparison uses manufacturer information checked November 17, 2026. It covers label amounts and formats, without ranking products by fertility outcomes. No hands-on testing or clinical brand comparison was performed.

Inositol product labels: serving units and formulation differences
Product / sourceAmount per labeled servingFormat and practical differenceLimit
Ovasitol classic by Theralogix2,000 mg myo-inositol + 50 mg D-chiro-inositolOne packet or one level scoop of powder; do not substitute Ovasitol PlusA 40:1 formula does not establish better pregnancy outcomes
Wholesome Story Myo + D-Chiro Inositol2,000 mg myo-inositol + 50 mg D-chiro-inositolFour capsules per serving, rather than one capsuleCompare full ingredients and exact variant; same ratio does not prove clinical equivalence
Jarrow Inositol 750 mg750 mg inositolOne veggie capsule; the current manufacturer page documents capsules, not the powder previously describedThe label does not list a myo/D-chiro combination; do not infer an equivalent trial regimen

A serving amount is not necessarily a total daily amount or a personal prescription. Check the actual bottle or packet, since product lines and labels can change. If using testing or certification as a selection criterion, confirm the exact variant and the scope of that assessment; it cannot prove a fertility benefit.

Can Myo-Inositol Replace Metformin or Fertility Treatment?

A finding of fewer gastrointestinal effects in some comparisons is not proof that treatments have identical fertility outcomes or that the prescription should be stopped. The guideline-informing review found uncertainty across outcomes, and the broader clinical guideline distinguishes metabolic management from ovulation induction. Fitz review; clinical guideline.

Likewise, a newer trial of inositol added to letrozole does not demonstrate that the supplement alone produces the same results. Discuss the actual comparison and the expected endpoint before substituting treatments or adding a product.

Pregnancy Evidence Is a Separate Question

A 2025 multicenter randomized trial enrolled 464 pregnant participants with PCOS and compared 4 g/day myo-inositol plus folic acid with a folic-acid control. It found no significant reduction in the combined outcome of gestational diabetes, preeclampsia or preterm birth. This was a pregnancy-complication trial, not a trial of achieving conception. van der Wel et al., 2025.

A 2026 meta-analysis in a broader pregnancy/preconception population reported a gestational-diabetes signal, using studies searched through April 2025. Its different population and evidence window should not be collapsed with the later PCOS-specific trial into either a universal benefit or a blanket safety assurance. 2026 review.

Side Effects, Medicines and Combination Use

Being naturally present in food or the body does not establish supplement safety at every amount, throughout pregnancy or in combination with medicines. Gastrointestinal effects and the quality of adverse-event reporting should be considered alongside benefits. Inform the care team about the exact product, amount, other supplements and glucose-lowering treatment.

This guide does not declare an inositol–CoQ10–vitamin/mineral stack interaction-free. It does not supply instructions for adjusting metformin, continuing during pregnancy or stopping before a procedure. Those decisions need the clinician or pharmacist managing the treatment.

If You Do Not Have PCOS, or Are Asking About Male Fertility

A selected PCOS population is not a stand-in for everyone trying to conceive. ESHRE guidance does not recommend routine myo-inositol use in non-PCOS women undergoing IVF and is also cautious about use in PCOS IVF. Ovarian-stimulation guideline.

Male fertility is another distinct clinical question. Do not turn an ovarian mechanism into a male supplement recommendation, or assume another stack is automatically preferable. Our male fertility guide provides related context.

Questions to Ask Before Choosing a Product

  • What specific outcome would justify taking it in my situation?
  • Does the relevant study match my diagnosis and other treatment?
  • Does the label show milligrams per capsule, per packet or per multi-capsule serving?
  • Is the formula the same as the one studied, and does any certificate apply to this exact product?
  • What risks and uncertainties remain, and what would prompt reassessment?

Frequently Asked Questions

Does myo-inositol restore ovulation in everyone with PCOS?

No dependable success rate is established for every patient. Some studies report favorable findings, but the current infertility recommendation remains experimental and evidence certainty varies.

Is 40:1 the best ratio for fertility?

It is a common formulation ratio, not proof of a universally optimal fertility treatment. Current guideline evidence does not establish a single recommended type or combination.

How long should I take it before IVF?

A study preparation period is not an individualized start date. Ask the IVF team about the evidence and the planned treatment rather than assuming every patient should take it for three months.

Can I combine it with a prenatal and CoQ10?

The full ingredient and medicine list needs review. Combining products with different proposed mechanisms does not establish effectiveness or interaction-free use.

Do food sources mean I need a supplement to reach a fertility dose?

No universal fertility dose is established here. The fact that a trial used more than a dietary amount does not create a nutritional requirement or prove that supplementation is necessary.

Related Guides

These articles address separate questions; linking them does not establish that their products should be combined.

Research Sources

These references identify the studies discussed above. Their presence does not mean every study demonstrates a fertility benefit or applies to every reader.

Research and guidance checked November 17, 2026. This is an editorial source review, not an individual clinical assessment or a guarantee of treatment benefit.

Medical information: Educational content does not replace diagnosis or treatment by a qualified healthcare professional. Review medicines, pregnancy and supplement decisions with your care team.

Scroll to Top